Review Articles
Managing athlete’s foot
South African Family Practice | Vol 60, No 5 : September/October| a4911 |
DOI: https://doi.org/10.4102/safp.v60i5.4911
| © 2019 Nkatoko Freddy Makola, Nicholus Malesela Magongwa, Boikgantsho Matsaung, Gustav Schellack, Natalie Schellack
| This work is licensed under CC Attribution 4.0
Submitted: 25 October 2019 | Published: 23 October 2018
Submitted: 25 October 2019 | Published: 23 October 2018
About the author(s)
Nkatoko Freddy Makola, Sefako Makgatho Health Sciences University, South AfricaNicholus Malesela Magongwa, Sefako Makgatho Health Sciences University, South Africa
Boikgantsho Matsaung, Sefako Makgatho Health Sciences University, South Africa
Gustav Schellack, Clinical research professional, pharmaceutical industry, South Africa
Natalie Schellack, Sefako Makgatho Health Sciences University, South Africa
Full Text:
PDF (187KB)Abstract
This article is aimed at providing a succinct overview of the condition tinea pedis, commonly referred to as athlete’s foot. Tinea pedis is a very common fungal infection that affects a significantly large number of people globally. The presentation of tinea pedis can vary based on the different clinical forms of the condition. The symptoms of tinea pedis may range from asymptomatic, to mild-to-severe forms of pain, itchiness, difficulty walking and other debilitating symptoms. There is a range of precautionary measures available to prevent infection, and both oral and topical drugs can be used for treating tinea pedis. This article briefly highlights what athlete’s foot is, the different causes and how they present, the prevalence of the condition, the variety of diagnostic methods available, and the pharmacological and non-pharmacological management of the condition.
Keywords
athlete’s foot; tinea pedis; dermatophyte; fungal infection; allylamines; azole antifungals; griseofulvin; terbinafine
Metrics
Total abstract views: 2495Total article views: 776